SCHEMBL29659742

SCHEMBL29659742

CN(C)c1nc(NCc2ccco2)c2ncn(C3CCCO3)c2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ YTHDC1 Q96MU7 1/20 0.45
▸ CDK1 P06493 3/20 0.43
▸ CCNB2 O95067 1/20 0.43
▸ CCNB1 P14635 1/20 0.43
▸ CCNB3 Q8WWL7 1/20 0.43
▸ FLT3 P36888 1/20 0.42
▸ CCNE1 P24864 3/20 0.41
▸ CDK2 P24941 3/20 0.41
▸ ADORA3 P0DMS8 3/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ ADORA2B P29275 1/20 0.41
▸ ADORA1 P30542 1/20 0.41
▸ TP53 P04637 2/20 0.41
▸ PAX8 Q06710 2/20 0.41
▸ SLC29A1 Q99808 1/20 0.41
▸ MITF O75030 1/20 0.41
▸ LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20547431 1.00 SMN1; SMN2 (0.48) SMN1; SMN2NPC1RAB9AYTHDC1CDK1
SCHEMBL20547186 0.97 NPC1 (0.52) SMN1; SMN2NPC1RAB9AYTHDC1CDK1
SCHEMBL29659624 0.97 NPC1 (0.52) SMN1; SMN2NPC1RAB9AYTHDC1CDK1
SCHEMBL20547205 0.92 SMN1; SMN2 (0.47) SMN1; SMN2NPC1RAB9AYTHDC1CDK1
SCHEMBL20547207 0.89 NPC1 (0.51) SMN1; SMN2NPC1RAB9AYTHDC1CDK1
SCHEMBL20547519 0.89 SMN1; SMN2 (0.45) SMN1; SMN2NPC1RAB9AYTHDC1CDK1
SCHEMBL29659620 0.87 YTHDC1 (0.51) SMN1; SMN2NPC1RAB9AYTHDC1CDK1
SCHEMBL20547532 0.87 YTHDC1 (0.51) SMN1; SMN2NPC1RAB9AYTHDC1CDK1
SCHEMBL30675139 0.87 CCNE1 (0.53) CDK1CCNB2CCNB1CCNB3FLT3
SCHEMBL20547474 0.86 FLT3 (0.49) SMN1; SMN2NPC1RAB9AYTHDC1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3615535-B1 9-(2-OXACYCLOALKYL)-9H-PURINE-2,6-DIAMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF SKIN DISORDERS UNIV PALACKEHO (CZ) 2022-06-15 — — EP disclosed
Send feedback